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Abstract  
Introduction: Case control studies that assess the burden and factors associated with undernutrition and anaemia among HAART naïve HIV 
infected children in Nigeria is very sparse. This will help to formulate nutritional programs among these children. Methods: Seventy HAART naive 
HIV infected children aged 18 months and above were as well as seventy age and sex matched HIV negative children were recruited from August 
2007 to January 2009 at Paediatric Clinic of Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria. Their bio data, WHO clinical 
stage, anthropometric measurements, haematocrit, serum albumin and CD4 counts were taken with other parameters according to a study 
proforma. Results: The prevalence of stunting, underweight and wasting among the HIV infected subjects were 48. 6%,58. 6% and 31. 4% 
respectively which as significantly higher than 28. 1%, 7. 1% and 28. 1% among the HIV negative controls. 20. 1% of the HIV infected children 
were marasmic compared to 2. 3% of the controls . Triple anthropometric failure was found in 7. 1% of the subjects as compared to none among 
the controls. Anaemia is significantly more prevalent among the subjects than the controls (70. 0% vs 31. 4%; p. Conclusion: Several years after 
availability of HAART, undernutrition and anaemia remain widely prevalent among newly presenting HAART naïve HIV infected Nigerian children . 
Nutritional supplementation and evaluation for anaemia still need close attention in the management of these children. 
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With an estimated 75,000 new child infections through mother to 
child transmission in 2010, [1]Nigeria has the highest mother-to-
child human immunodeficiency virus (HIV) transmission burden in 
the world. Many studies have shown that HIV infection worsens 
along with deterioration in the nutritional status of HIV infected 
children [2, 3]. Also, the two pathologies do interact to significantly 
increase mortality in these children [4, 5]. Initiating highly active 
antiretroviral drugs (HAART) has been shown to improve the 
nutritional status of HIV infected children [6, 7] but, in Nigeria, very 
few (less than 15%) of children in need of HAART are currently 
receiving them [8]. Moreover, research has shown that HAART 
alone is not enough to address nutritional problems in HIV infected 
persons [9]. Knowledge of the baseline nutritional status of HAART 
naïve HIV infected children will guide a nutritional plan of 
management that will either precede or accompany HAART. 
Anaemia is the most common haematologic manifestation of HIV 
with nutritional deficiencies, opportunistic infections and 
myelosuppression ranking among the major underlying causes [10]. 
Calis et al in a meta-analysis [11] showed that anaemia was a 
common complication occurring in 50-90% of children living with 
HIV in both resource-limited and resource-rich setting. It is also 
associated with poor quality of life [12]and increased mortality in 
HIV infected children. [10]The PEARLS Study done across 3 
continents has demonstrated that the prevalence of pre-ART 
anaemia is different even among diverse developing countries. [13] 
Hence, studies that are country- specific are needed to enable policy 
formulation for the particular country. Studies and surveys in Nigeria 
on the nutritional status and burden of anaemia in children have not 
evaluated HIV infected children as a specific group in relation to HIV 
uninfected children [14-18]. Moreover, recent review on anaemia in 
HIV infected children confirmed that there was no case-controlled 
study on anaemia in HIV infected children in Africa from their 
literature search [10]. This study set out to determine, by a cross-
sectional case-control study, the nutritional status of HAART naïve 
HIV infected Nigerian children presenting at an ART facility in Ile-Ife 
children presenting at an ART facility in Ile-Ife, South Western 
Nigeria. The prevalence and factors associated with anaemia were 





This was a hospital based cross-sectional, descriptive, and case-
control study. The study was conducted at the paediatric outpatient 
clinic of the Ife Hospital Unit (IHU) of ObafemiAwolowo University 
Teaching Hospitals Complex (OAUTHC) Ile-Ife, Osun State, Nigeria. 
The IHU is a three hundred bedded tertiary health facility. The 
paediatric outpatient clinic serves as the first port of call for most of 
the referred, transferred and newly identified HIV infected children. 
HIV negative general paediatric cases are seen simultaneously as 
well. This was the major source of the study controls aside from 
other paediatric related clinics such as paediatric orthopaedic and 
paediatric surgery clinics. All consecutive ambulant, non-acutely ill, 
newly diagnosed HIV infected children who are over 18 months of 
age during the study period and are also not on HAART were 
eligible for inclusion in the study if their caregivers give consent. 
Eighteen months was the age cut-off as DNA-PCR was not yet 
available for early infant diagnosis. Seventy patients and seventy 
age and sex matched HIV negative control group age matched 
patients were recruited over the 13 months from August 2007 to 
January 2009 Ethical clearance was obtained from the Research and 
Ethical Committee of the OAUTHC and consent was obtained from 
parents or guardian of recruited children. All recruited patients and 
control were interviewed by the investigators according to the 
proforma to determine their age, tribe and address. The educational 
status were ascertained according to Oyedeji social classification 
method. [19,20] The World Health Organization  
  
Revised Clinical Staging was also used to stage each HIV infected 
subject. [21]Weight and height were done according to standard 
methods. [22] All measurements were undertaken in duplicates by 
one of the investigators assisted by resident doctors, after which the 
mean was recorded. Pre-test information and post-test counseling 
were offered to all the patients in compliance with WHO Guidelines 
on Provider- initiated Testing and counseling (PITC). [23] HIV 
Screening was done in the Haematology laboratory of OAUTHC by 
rapid testing using the parallel method according to the National 
Algorithm of HIV testing in use at that time [24]. The two test kits 
were DetermineR HIV-1/2 (Abbot Laboratories, Japan)and Chembio 
HIV 1/2 STAT-PAKR (Chembio Diagnostic System Inc. New York, 
USA). A sample was considered positive if it was reactive to both 
tests kits and negative if reactive to none of the test kits. If a 
sample was reactive to only one of both kits it was considered 
indeterminate and a third test kit (Unigold) was utilised to confirm 
the subjects' HIV status. Afterwards, subjects as well as controls 
were offered post-test counselling and then introduced to the 
research if they grant consent. Subjects and controls were non-
fasting and the samples were collected in the morning (i. e. before 
12 noon). Albumin, liver enzymes and creatinine estimation, packed 
cell volume, CD4 and white cell counts were determined. CD4 count 
was determined using automated true volumetric Cyflow machine 
manufactured by Partec ® GMbH, Germany.  
  
The CD4 count and CD4% were used to categorise the HIV infected 
subjects immunological status ranging from non-significant 
immunosuppression to severe immunosuppression[21]. The 
Wellcome classification was used to categorize cases of protein 
energy malnutrition in children who were less than 60 months. The 
World Health Organization 2007 reference standards were used to 
determine the z-score of weight-for-age, height-for-age and weight-
for-height-for-age. Underweight, wasting and stunting were 
diagnosed when the weight-for-age (WA), weight-for- height (WH) 
and height-for-age (HA) were equal to or minus two z-scores 
respectively [25]. Anaemia (mild to moderate) was defined as 
haematocrit < 33% (equivalent to haemoglobin< 11 g/dL), and 
severe anaemia defined as haematocrit < 21 % (equivalent to 
haemoglobin of < 7 g/dL) based on the WHO description of 
anaemia [26-29]. After all these, all the HIV positive children were 
subsequently placed on cotrimoxazole prophylaxis, nutritional 
rehabilitation and other management measures as deemed 
appropriate. Criteria for the initiation of HAART follow the National 
Paediatric ART Guideline [8] also used in other Nigerian studies 
[30]. This closely mirrors the WHO Paediatric ART Guideline of 2006 
which was in use at the time the study was carried out [21].  
  
Data were entered into SPSS Statistical Software Package (SPSS 
version 11. 0, SPSS Inc. Chicago, Ill, USA). Results were expressed 
as the mean ± SD. Means were compared with student's "t" test 
while proportions and ratios were compared using the Pearson Chi 
squared tests (with Yates correction for sample size less than 5 in at 
least one cell). Z-scores of the anthropometric measurements were 
calculated using the Epilnfo statistical software package (EPI INFO 
version 7. 0. CDC, 2011) based on WHO Child Growth Standards 
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Results 
 
Over thirteen months, there were a total of 2057 new cases that 
were seen at the clinics of the paediatric outpatient department. 
Two thousand and one of them accepted PITC and a hundred and 
nine (5. 3%) of them were HIV infected. Thirty nine of the HIV 
infected patients were excluded from the study mainly on grounds 
of acute illness at presentation (25), tuberculosis (6), haematinic 
supplementation usage (5) and prior HAART usage (3). Seventy of 
them were finally recruited for the study and complete parameters 
were available for all of them.  
  
Sociodemographic Characteristics  
  
The study population comprised 70 HIV infected children (subjects) 
as well as 70 HIV negative children who served as the control. The 
age range of the subjects and control were the same (24 to 180 
months). (Table 1) The gender ratio was similar in both subjects 
and control (M: F = 1:1. 3; p=0. 87). Table 1 shows the 
distribution of the HIV infected children as well as the controls into 
the five socio-economic classes as described by Oyedeji [19]. There 
were more of the infected children in the lower socioeconomic class 
compared to the controls and the difference was statistically 
significant (p=0. 005).  
  
WHO Clinical and Immunological Stages of the HIV infected 
Subjects  
  
Table 1 shows the distribution of the HIV infected patients 
according to their WHO clinical and immunological stages. Forty 
seven (67. 1%) of them were in the late clinical stages (stages 3 
and 4) while 51 (72. 9%) presented with remarkable 
immunosuppression (severe and advanced immunological stages).  
  
Nutritional Status  
  
Table 2 shows the frequencies of stunting, wasting and 
underweight among the subjects as well as the controls. More of the 
infected children were stunted, wasted and underweight compared 
to the controls (p = 0. 001). Twelve (8. 6%) of them had all the 
three (stunting, wasting and underweight) together. Table 2 also 
shows the Wellcome classification of the subjects and controls who 
are less than sixty months. Significantly increased prevalence of 
underweight and marasmus were seen in the subjects as compared 
to the controls. There was no form of kwashiorkor observed in 
either the subjects or the controls. The mean (+SD) of serum 
albumin between infected and control were also significantly 
different (3. 2g/l+0. 7g/l and 4. 0g/l+0. 5g/l respectively; p=0. 001) 
(Table 1). Moreover 40(57. 1%) of the infected subjects were 
hypoalbuminaemic compared to 7 (14. 9%) of the control (p = 0. 
001). The prevalence of undernutrition among the HIV infected 
subjects did not differ significantly by age group i. e. 5 years vs 5-
10 years vs >10 years or gender but was higher among the lower 
socioeconomic classes (p=0. 006, 0. 07 and 0. 021 for underweight, 
wasting and stunting respectively) and the subjects with 
hypolbuminemia (p=0. 001, 0. 021 and 0. 007for underweight, 
wasting and stunting respectively). Comparing the prevalence of 
malnutrition across the clinical and immunological stages, there was 




The prevalence of anaemia is depicted in Figure 1. It is higher in 
the HIV infected subjects than the controls (70. 0% versus 31. 4%; 
pTable 3). In relation to nutritional status, the prevalence of 
anaemia among the stunted in the population was 17/22 (77. 2%) 
compared to 54/118 (45. 6%) among the non - stunted (p = 0. 
015). The prevalence of anaemia among the underweight was 
39/46 (84. 8%) compared to 32/94(34%) among those not 
underweight (p = 0. 001). The prevalence of anaemia among the 
wasted was 20/24 (83. 3%) as compared to 51/116(43. 9%) among 
the non - wasted. (p=0. 001) Among the infected, the mean HAZ, 
WAZ and WHZ, for those with severe anaemia versus (vs) moderate 
anaemia vs no anaemia were -3. 8 vs -2. 1 vs 1. 5; -3. 7 vs -2. 4 vs 
-1. 5; -2. 5 vs -1. 6 vs -0. 7 respectively. With worsening of 
anaemia, there was a progressive reduction in the mean 
anthropometric z-scores which was significant for WAZ (p = 0. 005) 





This prevalence of malnutrition in the HIV infected subjects (58. 
6%) was significantly more than in the HIV negative controls (7. 
1%). This compares favourably with the prevalence of 
undernutrition in Cameroun (56. 4%) [29], India (55%) [27] and 
56. 0% in a previous Nigerian Study [30]. It is however lower than 
the prevalence in Malaysia (21. 1%) [31]. The subjects in the 
Malaysian study being on HAART while our subjects are HAART 
naïve may be a contributory factor to this difference in prevalence. 
The prevalence of underweight, stunting and wasting in the controls 
were much lower than the regional average seen in the South 
Western Nigeria (13. 3%, 31. 2% and 7. 3% respectively) in the 
National Demographic Health Survey (NDHS) of 2008. [32] This 
could be explained by the fact that HIV screening was not done 
prior to the assessment of children who were involved in the survey. 
Hence it is possible that HIV infected children were included in the 
survey. Moreover, this is a hospital based study in contrad(istinction 
to the NDHS and majority 61. 4%) of the children who assess care 
at our facility are from the upper and middle socioeconomic classes. 
Applying the composite index of malnutrition [33], 40. 0% of the 
HIV infected children had both stunting and underweight, 27. 1% 
had both wasting and underweight while 17. 1% had triple 
anthropometric failure (stunting, wasting and underweight). The 
composite indices help to identify the children that are most in need 
of nutritional rehabilitation especially when resources for nutritional 
supplementation are insufficient. When malnutrition was assessed 
by the Wellcome classification among the under-fives, the 
prevalence of protein energy malnutrition was 35/43 (81. 4%) as 
compared to 3/43(7. 0%) among the controls. However, no case of 
kwashiorkor was seen. Kwashiorkor has been the least common 
form of protein energy malnutrts from Africa [34-36] and V infected 
children in many reports from Africa [34-37]. The most recent 
attempt to explain this observation is the genetically 
determinedheparansulfate proteoglycan (HSPG) deficiency which 
apparently reduces vertical transmission of HIV in infants who are 
predisposed to develop kwashiorkor later in life [38].  
  
Malnutrition was significantly more in the lower socioeconomic class 
(IV and V) than in the upper (I and II) and middle (III) classes. This 
reflects similar observations in other countries [9, 39, 40] Thus, 
measures to address undernutrition in children with HIV should 
involve an improvement in the socioeconomic status of the 
caregivers for those efforts to be effective and have a lasting 
impact. As a good number of them are orphans, national and non-
governmental orphan and vulnerable children (OVC) programs 
should place emphasis on nutritional supplementation and 
nutritional education of the caregivers With progressive worsening 
of the clinical stage and the degree of immunosuppression, the 
prevalence of underweight, wasting and stunting were increased. 
Undernutrition and HIV infection in children are interwoven, with 
HIV causing undernutrition, and undernutrition leading to rapid HIV 
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disease progression [41]. In the CHAP Trial,underweight was a 
predictor of mortality among HIV-infected children [42]. As Sunguya 
et al [9] pointed out, though HAART initiation improves nutritional 
status, it is on its own, not sufficient to completely reverse the 
malnutrition present in this group of children.  
  
The prevalence of anaemia in the subjects [70. 0%] is comparable 
to the values of 77. 9%, 66. 0%, 73% and 78% in Lagos [43], India 
[27], South Africa [44] and Malawi [45]. It is however lower than 
52. 5% in another Indian study [46] where the use of HAART by the 
subjects may have contributed to the lower prevalence. This 
prevalence of anaemia observed in this study is worrisome as recent 
studies have identified anaemia as a significant predictor of 
mortality among HIV infected children [10]. Also, the prevalence of 
anaemia showed significant increase with progressive clinical 
severity and immunosuppression affecting up to 87. 5% of patients 
with clinical stage IV and 75. 8% of patients with severe 
immunosuppression. These findings are in agreement with 
observations in India [46], South Africa [44]. Haematocrit < 24% is 
a WHO Revised Clinical Stage 3 feature which is a sufficient 
indication to initiate HAART [21]. In this study, 37/49 (75. 5%) of 
those with anaemia were in either Clinical stage 3 or 4 while 
39/49(79. 6%) were in the late immunologic categories (advanced 
and severe). Opportunistic infections, micronutrient (especially iron, 
folic acid and vitamin B12) deficiencies, cytokine induced 
myelosuppression, and HIV infection of bone marrow stroma [10] 
are some of the adduced reasons as all these events appear or 
worsen with disease progression. The high prevalence of anaemia 
and its equally high prevalence among the patients that present 
with late stages suggest that the presence and degree of anaemia 
should be carefully evaluated prior to HAART commencement 
moreso as the first line paediatric ART in most developing nations 
include zidovudine which is well known to induce anaemia. The case 
control nature of this study is its major strength. The exclusion of 
HIV infected children with major confounding variables such as 
HAART, nutritional supplementation, acute illnesses and tuberculosis 
is another. The lack of determination of dietary intake and food 
security in the homes of these children is a limitation of this study. 
However, the educational level and occupation of the caregivers 
which are the determinants of the social class in this study have a 





This study highlights the huge burden of malnutrition and anaemia 
among HIV infected children in Nigeria which has remained 
unchanged five years after a previous report from the same centre 
[48]. Also, a significant proportion of these HIV infected children 
have multiple concurrent anthropometric failures. These are 
believed to be the population that are in more urgent need of 
supplementation in clinics with scarce resources. It has shown that 
social class is an important determinant of anaemia and 
malnutrition. Hence long term efforts to mitigate this double burden 
should also improve the economic status of these children. The high 
provider initiated counselling and testing uptake rate in this study 
(97. 2%) is encouraging. This shows that if access to counselling 
and testing is increased, more children would be diagnosed early 
and enrolled before the disease progresses with consequent 
anaemia and malnutrition. A study on the long term (5 years, for 
instance) impact of HAART as well as nutritional supplementation on 
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Table 2: Prevalence of malnutrition among subjects and controls by various criteria 
Variables Infected Control P 
Malnutrition by Anthropometry Z-core       
Stunted (HAZ <-2) 34(48.6) 2(28.6) 0.001 
Wasted (WHZ <-2) 22(31.4) 2(28.6) 0.001 
Underweight (WAZ <-2) 41(58.6) 5(7.1) 0.001 
Malnutrition by Welcome Classification (Age <60months)       
Underweight 26(60.5) 2(4.7) 0.001 
Marasmus  9(20.9) 1(2.3) 0.001 
Kwashiorkor  -- -- -- 
Marasmus Kwashiorkor -- -- -- 
Normal  8(18.6) 40(93.0) 0.001 
Prevalence of multiple co-existing malnutrition (By 
combined anthropometry z-scores) 
      
Stunting and Wasting 13(9.3) 0(0.0) 0.001 
Wasting and Underweight  19(27.1) 2(2.9) 0.001 
Stunting and Underweight 28(40.0) 3(4.3) 0.001 





Table 1: Demographic, clinical and laboratory profile of subjects and controls 
Variables Infected Control 
Age Range (months)            
Age Group 24 – 180 24 – 180 
18-59months (n, %) 43 (61.4) 43 (61.4) 
60-119months (n, %) 21 (30.0) 22 (31.4) 
120-227months (n, %) 6 (8.6) 5 (7.1) 
Mean Age + SD (months) 58.4 + 37.8 58.01 + 38.1 
Gender (M vs F)   
*Social Class (n, %) 40 vs 30 39 vs 31 
I -- 9 (112.9) 
II 14 (20.0) 19 (27.1) 
III 16 (22.9) 15 (21.4) 
IV 27 (38.9) 13 (18.6) 
V   
Anthropometry Z Scores 13 (18.6) 14 (20.0) 
Median WAZ (25, 75) Male -0.18(-0.62, 0.59) -0.35(-0.54, 0.38) 
Median WAZ (25,75) female -0.53(-0.81, 0.36) -0.51(-0.66, -0.15) 
Median HAZ (25, 75) Male -0.13(-0.67, 0.70) -0.22(-0.68, 0.79) 
Median HAZ (25, 75) female -0.61(-0.88, 0.46) -0.53(-0.83, 0.18) 
Median WHZ (25, 75) Male -1.34(-2.29, -0.21) -0.34(-0.89, 0.09) 
Median WHZ (25,75) female -1.13(-1.87, -0.44) -0.32(-1.11, 0.00) 
#Mean + SD Serum albumin (g/l) 3.2 + 0.7 4.0 + 0.5 
#Mean + SD CD4 count (cells/ml) 611.4 + 444.5 1388.2 + 556.5 
#Mean + SD CD4 % (%) 18.8 + 13.2 35.4 + 4.4 
#Anaemic N (%)   
Clinical Stage (n, %) 49 (70.0) 22 (31.4) 
1 8 (11.4) -- 
2 15 (21.4) -- 
3 31 (44.3) -- 
4   
Immunological Stage (n, %) 16 (22.9) -- 
Not Significant Immunosuppression 4 (5.7) -- 
Mild Significant Immunosuppression 15 (21.4) -- 
Advanced Significant Immunosuppression 18 (25.7) -- 
Severe Significant Immunosuppression 33 (47.1) -- 
* Social class is by Oyedeji method (ref 19, 20);     # p value is significant (<0.05) 
Page number not for citation purposes 8 
Table 3: Prevalence of anaemia and hypoalbuminemia, by clinical and immunological 
Variable  N Haematocrit p-value Serum Albumin p-value 
Not 
Anaemic 
Anaemic Hypoalbuminemia Normal 
albumin 
Total   21 (30.0%) 49(70.0%) 40(57.1) 
 
Clinical stage 70      0.016 30(42.9) 0.001 




2 15 5(33.3) 10(66.7) 6(40.0) 9(60.0) 
3 31 8(25.8) 23(74.2) 18(58.1) 13(41.9) 
4  2(12.5) 14(87.5) 15(93.8) 
 
Immunological  16    0.157†  1(6.25)   0.011 
None 4 3(75.0) 1(25.0) 1(25.0) 3(75.0) 
Mild 15 6(40.0) 9(60.0) 4(26.7) 11(73.3) 
Advanced 18 4(22.2) 14(77.8)  14(77.8) 
 
 
stages among the HIV infected subjects 









Figure 1: Prevalence of mild-moderate and severe anaemia in the HIV infected 
subjects and HIV negative controls 
 
 
 
 
 
 
 
 
 
 
 
 
